Tim Davis retweeted
We have enrolled our 1st patient into the REACH clinical trial led by @gpradil2 Dr. Gustavo Pradilla. This is the 1st study to investigate the use of minimally invasive parafascicular surgery for deep ICH, particularly within anterior basal ganglia. #neurosurgery #REACH
Tim Davis retweeted
Learning more about fluorescence guided surgery from the best @hadjiMDPhD who brought 5-ala to America and is current @NSTumorSection president. @subcorticalsurg #SSG2024
Tim Davis retweeted
In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full results: nej.md/3VPYggf
ALT Top: Illustration of intracerebral hemorrhage, as well as two treatment assigned during the ENRICH trial: minimally invasive trans-sulcal parafascicular surgery plus medical management or medical management alone Bottom: Bar chart showing that among evaluable patients, the mean utility-weighted modified Rankin scale score was better with surgery than with medical management alone
Tim Davis retweeted
The SSG is committed to academic excellence. We will sponsor 10 #nsgy senior residents or fellows to attend #SSG2024. This includes free registration, hotel accommodation @StJulienHotel, and $500 flight reimbursement. Contact [email protected] for more information.
Tim Davis retweeted
Hand-held blue excitation light to complement your existing fluorescence-guided surgical workflow - See new possibilities with Myriad SPECTRA.
#neurosurgery #InnovativeMedicalDevices
Tim Davis retweeted
May is national #strokeawarenessmonth. Read about how the revolutionary results of the #ENRICHtrial published by @NEJM are contributing to advancements in surgical patient care for intracerebral hemorrhage. bit.ly/3vDMJ9r
Tim Davis retweeted
@bainmd @ClevelandClinic provides commentary on the positive #ENRICH results. We are excited to have him facilitate the #MIPS pre-meeting workshop at #SSG2024. You can read Dr. Bain's thoughts here ➡️ neurologylive.com/view/first…
Tim Davis retweeted
Symposium director Dr. Manmeet Ahluwalia (@BrainTumorDoc) & #MiamiCancerInstitute CEO Dr. Michael Zinner (@MichaelZinnerMD) kick off with opening remarks and an overview of today’s agenda highlighting targeted therapies for solid tumor malignancies🎯💡
#MCIPrecisionOncology – at Miami, FL
Tim Davis retweeted
@NeurosurgeryUSC was thrilled to be an initial site for the #ENRICH trial just published in @NEJM. Congrats to my friend Gustavo Pradilla and @EmoryNeurosurg!
#Neurosurgery #Stroke – at Los Angeles, CA
In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf
ALT Figure showing the distribution of surgery effect and observed scores on the modified Rankin scale
Tim Davis retweeted
In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf
ALT Figure showing the distribution of surgery effect and observed scores on the modified Rankin scale
Tim Davis retweeted
Treatment changing results for patients with intracerebral hemorrhage. Congratulations to @gpradil2 and investigators!!
@EmoryBrain @EmoryMedicine @EmorySkullBase @EmoryNeurosurg
Editorial: New Hope for Adults with Lobar Intracerebral Hemorrhage nej.md/49uI0ob
Tim Davis retweeted
Data supports MIPS for consistent, repeatable access to subcortical brain tumors. These pre and post-operative scans are select examples of progress towards a zero-footprint surgery: bit.ly/3VynL5w
#neurosurgery #MIPS #InnovativeMedicalDevices
Tim Davis retweeted
We look forward to seeing you at #ISC2024 tomorrow in Phoenix, AZ. Visit booth 549 to learn more about #ENRICHtrial results. The first positive surgical trial in the deadliest type of stroke. #ICH
bit.ly/3R93S1k
Tim Davis retweeted
Our integrated system approach addresses unmet needs of neurosurgeons and improves #ICH patient outcomes as demonstrated in #ENRICHtrial. Learn more about #BrainPath for access and #NOVUSmyraid for illumination and evacuation of clot here: niconeuro.com/our-integrated…
Tim Davis retweeted
Why choose NICO? We provide a complete MIS product solution. Procedural efficiencies driven by technologies that are part of an integrated system to ACCESS, ILLUMINATE, REMOVE, COLLECT and PRESERVE that address unmet needs of the neurosurgeon.
#MIPS #neurosurgery #nsgy
Tim Davis retweeted
This week, we will participate in the J.P. Morgan 42nd Annual Healthcare Conference in San Francisco. We are honored to participate and showcase NICO’s successes in revolutionizing neurosurgery. To learn more about NICO, visit us at NICOneuro.com.
#neurosurgery #ENRICH
Tim Davis retweeted
Your favorite #neurosurgery meeting will return to Boulder, August 1-3, 2024. Mark your calendar. More details to come in the new year. #SSG2024
Tim Davis retweeted
Why do we need advances in intracerebral hemorrhage (ICH)? Two million people suffer these strokes each year, and approximately 50% will die within 30 days. Together, we can help improve clinical outcomes in ICH. #ENRICHtrial
bit.ly/3R93S1k
Tim Davis retweeted
Watch @ddonoho at @ChildrensNatl remove a giant inflammatory postinfectious intraventricular mass. Using the Myriad, Dr. Donoho was able to debride the occluded ventricular catheter & open the foramina of Monro by resecting the mass & residual scar tissue. youtube.com/watch?v=22uq_eEl…
